Colgate-Palmolive
About: Since its founding in 1806, Colgate-Palmolive has grown to become a leading player in the household and personal care arena. In addition to its namesake oral care line (which accounts for more than 40% of its total sales), the firm manufactures shampoos, shower gels, deodorants, and homecare products that are sold in over 200 countries. International sales account for about 70% of its total business, including approximately 45% from emerging regions. It also owns specialty pet food maker Hill's (around one fifth of sales), which primarily sells its products through veterinarians and specialty pet retailers.
Employees: 34,000
Fund manager confidence
Based on 2024 Q3 regulatory filings by fund managers ($100M+ AUM)
82% more first-time investments, than exits
New positions opened: 184 | Existing positions closed: 101
5% more funds holding
Funds holding: 1,792 [Q2] → 1,875 (+83) [Q3]
3% more capital invested
Capital invested by funds: $66.6B [Q2] → $68.6B (+$1.99B) [Q3]
1% less call options, than puts
Call options by funds: $475M | Put options by funds: $479M
5% less repeat investments, than reductions
Existing positions increased: 646 | Existing positions reduced: 680
3.0% less ownership
Funds ownership: 83.72% [Q2] → 80.72% (-3.0%) [Q3]
10% less funds holding in top 10
Funds holding in top 10: 10 [Q2] → 9 (-1) [Q3]
Research analyst outlook
5 Wall Street Analysts provided 1 year price targets over the past 3 months
5 analyst ratings
Wells Fargo Chris Carey 33% 1-year accuracy 11 / 33 met price target | 0%downside $92 | Underweight Maintained | 28 Oct 2024 |
TD Cowen Robert Moskow 46% 1-year accuracy 21 / 46 met price target | 20%upside $110 | Buy Maintained | 28 Oct 2024 |
Stifel Mark Astrachan 45% 1-year accuracy 13 / 29 met price target | 10%upside $101 | Hold Downgraded | 28 Oct 2024 |
JP Morgan Andrea Teixeira 45% 1-year accuracy 24 / 53 met price target | 24%upside $114 | Overweight Maintained | 11 Oct 2024 |
Piper Sandler Korinne Wolfmeyer 38% 1-year accuracy 15 / 40 met price target | 31%upside $121 | Overweight Initiated | 24 Sept 2024 |
Financial journalist opinion
Based on 9 articles about CL published over the past 30 days